We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+13.88%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$2.73B
AUM Growth
+$76.2M
Cap. Flow
-$255M
Cap. Flow %
-9.36%
Top 10 Hldgs %
39.9%
Holding
430
New
14
Increased
31
Reduced
325
Closed
21

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$26.6M
2
T icon
AT&T
T
+$25.7M
3
KLAC icon
KLA
KLAC
+$14.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$14M
5
LLY icon
Eli Lilly
LLY
+$9.75M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$32.8M
2
VZ icon
Verizon
VZ
+$24.2M
3
AAPL icon
Apple
AAPL
+$20M
4
MRK icon
Merck
MRK
+$19.3M
5
MSFT icon
Microsoft
MSFT
+$18.5M

Sector Composition

Rank Sector Weight
1 Technology 32.96%
2 Financials 15.52%
3 Healthcare 13.74%
4 Consumer Discretionary 11.22%
5 Communication Services 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWONK icon
401
Liberty Media Series C
FWONK
$25.7B
$208K 0.01%
3,300
EMN icon
402
Eastman Chemical
EMN
$8.53B
$180K 0.01%
2,000
SIRI icon
403
SiriusXM
SIRI
$9.63B
$168K 0.01%
3,063
HOOD icon
404
Robinhood
HOOD
$84.1B
$140K 0.01%
+11,000
New +$109K
FOX icon
405
Fox Class B
FOX
$23.2B
$133K ﹤0.01%
4,800
-3,300
-41% -$92.7K
PACB icon
406
Pacific Biosciences
PACB
$357M
$132K ﹤0.01%
13,476
-9,724
-42% -$79.5K
BIO icon
407
Bio-Rad Laboratories Class A
BIO
$9.44B
$129K ﹤0.01%
400
LCID icon
408
Lucid Motors
LCID
$2.6B
$125K ﹤0.01%
2,970
RXRX icon
409
Recursion Pharmaceuticals
RXRX
$1.78B
$73.8K ﹤0.01%
7,482
+582
+8% +$4.15K
AMED
410
DELISTED
Amedisys
AMED
-13,500
Closed -$1.26M
ARMK icon
411
Aramark
ARMK
$16B
-13,989
Closed -$350K
CME icon
412
CME Group
CME
$93.6B
-5,900
Closed -$1.18M
ETR icon
413
Entergy
ETR
$49.7B
-18,800
Closed -$870K
GNRC icon
414
Generac Holdings
GNRC
$12.6B
-3,200
Closed -$349K
INCY icon
415
Incyte
INCY
$24.6B
-8,800
Closed -$508K
KVUE icon
416
Kenvue
KVUE
$36.4B
-69,482
Closed -$1.4M
O icon
417
Realty Income
O
$58.7B
-30,100
Closed -$1.5M
PLMR icon
418
Palomar
PLMR
$3.52B
-15,000
Closed -$761K
ROKU icon
419
Roku
ROKU
$22.4B
-5,800
Closed -$409K
SEE
420
DELISTED
Sealed Air
SEE
-5,653
Closed -$186K
STEM icon
421
Stem
STEM
$51.4M
-20,000
Closed -$1.7M
TSLA icon
422
Tesla
TSLA
$1.31T
-130,900
Closed -$32.8M
WHR icon
423
Whirlpool
WHR
$2.85B
-2,900
Closed -$388K
WOLF icon
424
Wolfspeed
WOLF
$1.56B
-5,300
Closed -$202K
XRAY icon
425
Dentsply Sirona
XRAY
$2.32B
-9,700
Closed -$331K

Similar funds

E. Ohman J:or Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, E. Ohman J:or Asset Management held 430 positions worth $2.73B, up 2.9% from $2.65B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

E. Ohman J:or Asset Management withdrew a net $255M in Q4 2023, closing 21 positions and reducing 325 holdings. Its most notable exit was Tesla, an estimated $32.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.

Against the trend, E. Ohman J:or Asset Management opened a new position in Regeneron Pharmaceuticals worth $3.69M.

  • E. Ohman J:or Asset Management's largest Q4 2023 buy was Regeneron Pharmaceuticals: 4,200 shares worth $3.69M.
  • E. Ohman J:or Asset Management added most to Intercontinental Exchange in Q4 2023, an estimated $26.6M increase.
  • E. Ohman J:or Asset Management's biggest Q4 2023 reduction was Verizon, cutting an estimated $24.2M.
  • E. Ohman J:or Asset Management fully exited Tesla in Q4 2023, selling an estimated $32.8M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 40% of its $2.73B portfolio in Q4 2023.
  • E. Ohman J:or Asset Management opened 14 new positions and closed 21 in Q4 2023.
  • E. Ohman J:or Asset Management's portfolio value rose 2.9% quarter-over-quarter to $2.73B.

Based on E. Ohman J:or Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.